Follow the people · Insider
George Eric Davis
George Eric Davis files insider transactions with the SEC as an evp, chief legal officer of Biomarin Pharmaceutical (BMRN). We hold 2 disclosed purchases and sales filed since 22 November 2006, 1 of them in the last 90 days.
- Files forBMRN
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 November 2006 — 2 September 2026EVP, Chief Legal Officer · Biomarin Pharmaceutical (BMRN)412 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- was granted 6,177 shares of Biomarin PharmaceuticalSEC Form 426 February 2026Common Stock · traded 25 February 2026 · filed 26 February 2026
- was granted 6,675 shares of Biomarin PharmaceuticalSEC Form 426 February 2026Common Stock · traded 25 February 2026 · filed 26 February 2026
- was granted 2,372 shares of Biomarin PharmaceuticalSEC Form 426 February 2026Common Stock · traded 25 February 2026 · filed 26 February 2026
- ▼ sold on the open market 26,061 shares of Biomarin PharmaceuticalSEC Form 426 February 2026Common Stock · traded 26 February 2026 · filed 26 February 2026
- was granted 6,177 shares of Biomarin PharmaceuticalSEC Form 426 February 2026Common Stock · traded 25 February 2026 · filed 26 February 2026
- was granted 375 shares of Biomarin PharmaceuticalSEC Form 413 February 2026Common Stock · traded 30 April 2025 · filed 13 February 2026
- was granted 30,020 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 418 March 2025Stock Option (Right to Buy Common Stock) · traded 17 March 2025 · filed 18 March 2025
- had shares withheld for tax on 16,249 shares of Biomarin PharmaceuticalSEC Form 418 March 2025Common Stock · traded 14 March 2025 · filed 18 March 2025
- was granted 12,940 shares of Biomarin PharmaceuticalSEC Form 418 March 2025Common Stock · traded 17 March 2025 · filed 18 March 2025
- was granted 11,040 shares of Biomarin PharmaceuticalSEC Form 427 February 2025Common Stock · traded 25 February 2025 · filed 27 February 2025
- was granted 9,660 shares of Biomarin PharmaceuticalSEC Form 427 February 2025Common Stock · traded 25 February 2025 · filed 27 February 2025
- was granted 9,367 shares of Biomarin PharmaceuticalSEC Form 427 February 2025Common Stock · traded 25 February 2025 · filed 27 February 2025
- exercised options over 40,850 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 430 May 2024Stock Option (Right to Buy Common Stock) · traded 28 May 2024 · filed 30 May 2024
- exercised options over 40,850 shares of Biomarin PharmaceuticalSEC Form 430 May 2024Common Stock · traded 28 May 2024 · filed 30 May 2024
- ▼ sold on the open market 38,071 shares of Biomarin PharmaceuticalSEC Form 430 May 2024Common Stock · traded 28 May 2024 · filed 30 May 2024
- ▼ sold on the open market 2,779 shares of Biomarin PharmaceuticalSEC Form 430 May 2024Common Stock · traded 28 May 2024 · filed 30 May 2024
- exercised options over 1,850 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 46 May 2024Stock Option (Right to Buy Common Stock) · traded 2 May 2024 · filed 6 May 2024
- was granted 301 shares of Biomarin PharmaceuticalSEC Form 46 May 2024Common Stock · traded 30 April 2024 · filed 6 May 2024
- exercised options over 1,850 shares of Biomarin PharmaceuticalSEC Form 46 May 2024Common Stock · traded 2 May 2024 · filed 6 May 2024
- ▼ sold on the open market 1,850 shares of Biomarin PharmaceuticalSEC Form 46 May 2024Common Stock · traded 2 May 2024 · filed 6 May 2024
- ▼ sold on the open market 24,602 shares of Biomarin PharmaceuticalSEC Form 41 April 2024Common Stock · traded 28 March 2024 · filed 1 April 2024
- was granted 22,990 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 419 March 2024Stock Option (Right to Buy Common Stock) · traded 15 March 2024 · filed 19 March 2024
- was granted 10,260 shares of Biomarin PharmaceuticalSEC Form 419 March 2024Common Stock · traded 15 March 2024 · filed 19 March 2024
- had shares withheld for tax on 21,699 shares of Biomarin PharmaceuticalSEC Form 419 March 2024Common Stock · traded 15 March 2024 · filed 19 March 2024
- was granted 20,840 shares of Biomarin PharmaceuticalSEC Form 429 February 2024Common Stock · traded 27 February 2024 · filed 29 February 2024
- was granted 9,063 shares of Biomarin PharmaceuticalSEC Form 429 February 2024Common Stock · traded 27 February 2024 · filed 29 February 2024
- was granted 6,284 shares of Biomarin PharmaceuticalSEC Form 429 February 2024Common Stock · traded 27 February 2024 · filed 29 February 2024
- ▼ sold on the open market 13,764 shares of Biomarin PharmaceuticalSEC Form 414 December 2023Common Stock · traded 13 December 2023 · filed 14 December 2023
- ▼ sold on the open market 11,000 shares of Biomarin PharmaceuticalSEC Form 49 August 2023Common Stock · traded 8 August 2023 · filed 9 August 2023
- was granted 317 shares of Biomarin PharmaceuticalSEC Form 418 May 2023Common Stock · traded 28 April 2023 · filed 18 May 2023
- gave away 210 shares of Biomarin PharmaceuticalSEC Form 418 May 2023Common Stock · traded 16 May 2023 · filed 18 May 2023
- was granted 20,320 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 417 March 2023Stock Option (Right to buy Common Stock) · traded 15 March 2023 · filed 17 March 2023
- was granted 8,900 shares of Biomarin PharmaceuticalSEC Form 417 March 2023Common Stock · traded 15 March 2023 · filed 17 March 2023
- had shares withheld for tax on 3,025 shares of Biomarin PharmaceuticalSEC Form 417 March 2023Common Stock · traded 15 March 2023 · filed 17 March 2023
- had shares withheld for tax on 19,957 shares of Biomarin PharmaceuticalSEC Form 417 March 2023Common Stock · traded 16 March 2023 · filed 17 March 2023
- was granted 20,200 shares of Biomarin PharmaceuticalSEC Form 42 March 2023Common Stock · traded 28 February 2023 · filed 2 March 2023
- was granted 10,100 shares of Biomarin PharmaceuticalSEC Form 42 March 2023Common Stock · traded 28 February 2023 · filed 2 March 2023
- was granted 7,424 shares of Biomarin PharmaceuticalSEC Form 42 March 2023Common Stock · traded 28 February 2023 · filed 2 March 2023
- exercised options over 1,474 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 428 February 2023Stock Option (Right to buy Common Stock) · traded 24 February 2023 · filed 28 February 2023
- exercised options over 1,474 shares of Biomarin PharmaceuticalSEC Form 428 February 2023Common Stock · traded 24 February 2023 · filed 28 February 2023
- exercised options over 47,526 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 411 August 2022Stock Option (Right to buy Common Stock) · traded 9 August 2022 · filed 11 August 2022
- ▼ sold on the open market 3,690 shares of Biomarin PharmaceuticalSEC Form 411 August 2022Common Stock · traded 9 August 2022 · filed 11 August 2022
- exercised options over 47,526 shares of Biomarin PharmaceuticalSEC Form 411 August 2022Common Stock · traded 9 August 2022 · filed 11 August 2022
- ▼ sold on the open market 47,526 shares of Biomarin PharmaceuticalSEC Form 411 August 2022Common Stock · traded 9 August 2022 · filed 11 August 2022
- ▼ sold on the open market 7,398 shares of Biomarin PharmaceuticalSEC Form 411 July 2022Common Stock · traded 8 July 2022 · filed 11 July 2022
- exercised options over 15,347 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 44 May 2022Stock Option (Right to buy Common Stock) · traded 2 May 2022 · filed 4 May 2022
- was granted 341 shares of Biomarin PharmaceuticalSEC Form 44 May 2022Common Stock · traded 29 April 2022 · filed 4 May 2022
- exercised options over 15,347 shares of Biomarin PharmaceuticalSEC Form 44 May 2022Common Stock · traded 2 May 2022 · filed 4 May 2022
- ▼ sold on the open market 15,347 shares of Biomarin PharmaceuticalSEC Form 44 May 2022Common Stock · traded 2 May 2022 · filed 4 May 2022
- exercised options over 2,669 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 427 April 2022Stock Option (Right to buy Common Stock) · traded 25 April 2022 · filed 27 April 2022
- exercised options over 2,669 shares of Biomarin PharmaceuticalSEC Form 427 April 2022Common Stock · traded 25 April 2022 · filed 27 April 2022
- ▼ sold on the open market 6,129 shares of Biomarin PharmaceuticalSEC Form 423 March 2022Common Stock · traded 21 March 2022 · filed 23 March 2022
- was granted 26,520 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 417 March 2022Stock Option (Right to buy Common Stock) · traded 15 March 2022 · filed 17 March 2022
- was granted 11,040 shares of Biomarin PharmaceuticalSEC Form 417 March 2022Common Stock · traded 15 March 2022 · filed 17 March 2022
- had shares withheld for tax on 8,290 shares of Biomarin PharmaceuticalSEC Form 417 March 2022Common Stock · traded 15 March 2022 · filed 17 March 2022
- had shares withheld for tax on 1,252 shares of Biomarin PharmaceuticalSEC Form 417 March 2022Common Stock · traded 16 March 2022 · filed 17 March 2022
- was granted 9,370 shares of Biomarin PharmaceuticalSEC Form 410 March 2022Common Stock · traded 8 March 2022 · filed 10 March 2022
- ▼ sold on the open market 5,518 shares of Biomarin PharmaceuticalSEC Form 44 August 2021Common Stock · traded 2 August 2021 · filed 4 August 2021
- was granted 341 shares of Biomarin PharmaceuticalSEC Form 44 May 2021Common Stock · traded 30 April 2021 · filed 4 May 2021
- ▼ sold on the open market 2,584 shares of Biomarin PharmaceuticalSEC Form 44 May 2021Common Stock · traded 3 May 2021 · filed 4 May 2021
- ▼ sold on the open market 2,089 shares of Biomarin PharmaceuticalSEC Form 44 May 2021Common Stock · traded 3 May 2021 · filed 4 May 2021
- exercised options over 2,709 shares of Biomarin PharmaceuticalSEC Form 420 April 2021Common Stock · traded 19 April 2021 · filed 20 April 2021
- ▼ sold on the open market 2,709 shares of Biomarin PharmaceuticalSEC Form 420 April 2021Common Stock · traded 19 April 2021 · filed 20 April 2021
- exercised options over 2,709 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 420 April 2021Stock Option (Right to buy Common Stock) · traded 19 April 2021 · filed 20 April 2021
- had shares withheld for tax on 1,391 shares of Biomarin PharmaceuticalSEC Form 423 March 2021Common Stock · traded 22 March 2021 · filed 23 March 2021
- was granted 10,420 shares of Biomarin PharmaceuticalSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- had shares withheld for tax on 5,014 shares of Biomarin PharmaceuticalSEC Form 417 March 2021Common Stock · traded 15 March 2021 · filed 17 March 2021
- had shares withheld for tax on 1,252 shares of Biomarin PharmaceuticalSEC Form 417 March 2021Common Stock · traded 16 March 2021 · filed 17 March 2021
- was granted 25,650 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 417 March 2021Stock Option (Right to buy Common Stock) · traded 15 March 2021 · filed 17 March 2021
- was granted 339 shares of Biomarin PharmaceuticalSEC Form 44 May 2020Common Stock · traded 30 April 2020 · filed 4 May 2020
- ▼ sold on the open market 12,504 shares of Biomarin PharmaceuticalSEC Form 44 May 2020Common Stock · traded 1 May 2020 · filed 4 May 2020
- had shares withheld for tax on 3,309 shares of Biomarin PharmaceuticalSEC Form 424 March 2020Common Stock · traded 20 March 2020 · filed 24 March 2020
- was granted 28,790 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 417 March 2020Stock Option (Right to buy Common Stock) · traded 16 March 2020 · filed 17 March 2020
- had shares withheld for tax on 7,244 shares of Biomarin PharmaceuticalSEC Form 417 March 2020Common Stock · traded 13 March 2020 · filed 17 March 2020
- was granted 10,100 shares of Biomarin PharmaceuticalSEC Form 417 March 2020Common Stock · traded 16 March 2020 · filed 17 March 2020
- was granted 9,586 shares of Biomarin PharmaceuticalSEC Form 44 March 2020Common Stock · traded 3 March 2020 · filed 4 March 2020
- ▼ sold on the open market 3,190 shares of Biomarin PharmaceuticalSEC Form 427 November 2019Common Stock · traded 26 November 2019 · filed 27 November 2019
- was granted 309 shares of Biomarin PharmaceuticalSEC Form 47 June 2019Common Stock · traded 30 April 2019 · filed 7 June 2019
- gave away 300 shares of Biomarin PharmaceuticalSEC Form 47 June 2019Common Stock · traded 5 June 2019 · filed 7 June 2019
- had shares withheld for tax on 3,309 shares of Biomarin PharmaceuticalSEC Form 426 March 2019Common Stock · traded 22 March 2019 · filed 26 March 2019
- ▼ sold on the open market 3,363 shares of Biomarin PharmaceuticalSEC Form 426 March 2019Common Stock · traded 25 March 2019 · filed 26 March 2019
- ▼ sold on the open market 7,907 shares of Biomarin PharmaceuticalSEC Form 421 March 2019Common Stock · traded 19 March 2019 · filed 21 March 2019
- was granted 23,450 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 419 March 2019Stock Option (Right to buy Common Stock) · traded 15 March 2019 · filed 19 March 2019
- had shares withheld for tax on 6,648 shares of Biomarin PharmaceuticalSEC Form 419 March 2019Common Stock · traded 15 March 2019 · filed 19 March 2019
- was granted 9,370 shares of Biomarin PharmaceuticalSEC Form 419 March 2019Common Stock · traded 15 March 2019 · filed 19 March 2019
- was granted 11,853 shares of Biomarin PharmaceuticalSEC Form 45 March 2019Common Stock · traded 1 March 2019 · filed 5 March 2019
- had shares withheld for tax on 840 shares of Biomarin PharmaceuticalSEC Form 45 March 2019Common Stock · traded 1 March 2019 · filed 5 March 2019
- ▼ sold on the open market 1,400 shares of Biomarin PharmaceuticalSEC Form 418 September 2018Common Stock · traded 14 September 2018 · filed 18 September 2018
- ▼ sold on the open market 200 shares of Biomarin PharmaceuticalSEC Form 418 September 2018Common Stock · traded 14 September 2018 · filed 18 September 2018
- ▼ sold on the open market 616 shares of Biomarin PharmaceuticalSEC Form 418 September 2018Common Stock · traded 14 September 2018 · filed 18 September 2018
- ▼ sold on the open market 12,000 shares of Biomarin PharmaceuticalSEC Form 417 September 2018Common Stock · traded 13 September 2018 · filed 17 September 2018
- was granted 309 shares of Biomarin PharmaceuticalSEC Form 46 June 2018Common Stock · traded 30 April 2018 · filed 6 June 2018
- had shares withheld for tax on 1,414 shares of Biomarin PharmaceuticalSEC Form 46 June 2018Common Stock · traded 4 June 2018 · filed 6 June 2018
- had shares withheld for tax on 3,308 shares of Biomarin PharmaceuticalSEC Form 427 April 2018Common Stock · traded 22 March 2018 · filed 27 April 2018
- was granted 11,601 shares of Biomarin PharmaceuticalSEC Form 426 April 2018Common Stock · traded 26 February 2018 · filed 26 April 2018
- ▼ sold on the open market 3,350 shares of Biomarin PharmaceuticalSEC Form 427 March 2018Common Stock · traded 23 March 2018 · filed 27 March 2018
- had shares withheld for tax on 3,295 shares of Biomarin PharmaceuticalSEC Form 426 March 2018Common Stock · traded 22 March 2018 · filed 26 March 2018
- ▼ sold on the open market 3,818 shares of Biomarin PharmaceuticalSEC Form 420 March 2018Common Stock · traded 16 March 2018 · filed 20 March 2018
- had shares withheld for tax on 3,757 shares of Biomarin PharmaceuticalSEC Form 419 March 2018Common Stock · traded 15 March 2018 · filed 19 March 2018
- was granted 12,120 shares of Biomarin PharmaceuticalSEC Form 419 March 2018Common Stock · traded 15 March 2018 · filed 19 March 2018
- was granted 38,760 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 419 March 2018Stock Option (Right to buy Common Stock) · traded 15 March 2018 · filed 19 March 2018
- ▼ sold on the open market 2,105 shares of Biomarin PharmaceuticalSEC Form 47 March 2018Common Stock · traded 5 March 2018 · filed 7 March 2018
- had shares withheld for tax on 2,071 shares of Biomarin PharmaceuticalSEC Form 46 March 2018Common Stock · traded 2 March 2018 · filed 6 March 2018
- was granted 11,523 shares of Biomarin PharmaceuticalSEC Form 428 February 2018Common Stock · traded 26 February 2018 · filed 28 February 2018
- gave away 200 shares of Biomarin PharmaceuticalSEC Form 414 February 2018Common Stock · traded 22 November 2017 · filed 14 February 2018
- exercised options over 30,000 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 45 February 2018Stock Option (Right to buy Common Stock) · traded 1 February 2018 · filed 5 February 2018
- exercised options over 30,000 shares of Biomarin PharmaceuticalSEC Form 45 February 2018Common Stock · traded 1 February 2018 · filed 5 February 2018
- ▼ sold on the open market 30,000 shares of Biomarin PharmaceuticalSEC Form 45 February 2018Common Stock · traded 1 February 2018 · filed 5 February 2018
- ▼ sold on the open market 1,200 shares of Biomarin PharmaceuticalSEC Form 44 December 2017Common Stock · traded 30 November 2017 · filed 4 December 2017
- acquired or disposed of, other an unstated number of shares of Biomarin PharmaceuticalSEC Form 413 October 2017Common Stock · traded 16 December 2015 · filed 13 October 2017
- exercised options over 9,844 shares of Biomarin PharmaceuticalSEC Form 427 June 2017Common Stock · traded 23 June 2017 · filed 27 June 2017
- ▼ sold on the open market 9,844 shares of Biomarin PharmaceuticalSEC Form 427 June 2017Common Stock · traded 23 June 2017 · filed 27 June 2017
- exercised options over 9,844 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 427 June 2017Stock Option (Right to buy Common Stock) · traded 23 June 2017 · filed 27 June 2017
- exercised options over 5,464 shares of Biomarin PharmaceuticalSEC Form 413 June 2017Common Stock · traded 9 June 2017 · filed 13 June 2017
- exercised options over 3,775 shares of Biomarin PharmaceuticalSEC Form 413 June 2017Common Stock · traded 9 June 2017 · filed 13 June 2017
- exercised options over 5,464 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 413 June 2017Stock Option (Right to buy Common Stock) · traded 9 June 2017 · filed 13 June 2017
- exercised options over 3,775 shares of Biomarin Pharmaceutical (a derivative holding)SEC Form 413 June 2017Stock Option (Right to buy Common Stock) · traded 9 June 2017 · filed 13 June 2017
- ▼ sold on the open market 9,471 shares of Biomarin PharmaceuticalSEC Form 47 June 2017Common Stock · traded 5 June 2017 · filed 7 June 2017
- had shares withheld for tax on 1,488 shares of Biomarin PharmaceuticalSEC Form 46 June 2017Common Stock · traded 2 June 2017 · filed 6 June 2017
- had shares withheld for tax on 1,096 shares of Biomarin PharmaceuticalSEC Form 417 May 2017Common Stock · traded 15 May 2017 · filed 17 May 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.